Clinical Trial Update: Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and potential neuropsychiatric benefits of sapropterin dihydrochloride in phenylketonuria patients; the trial results were c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 3 | Status: COMPLETED | Results posted: 2016-02-01